A Worldwide, Phase I, Dose-Escalating Study of a 3-Dose Regimen of the MRKAd5 (Clade B) Vaccine in Healthy Adults (V520-018)(COMPLETED)
This study has been completed.
Sponsor:
Merck
Collaborators:
HIV Vaccine Trials Network
Information provided by:
Merck
ClinicalTrials.gov Identifier:
NCT00849732
First received: February 20, 2009
Last updated: March 25, 2011
Last verified: March 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | February 2011 |
| Primary Completion Date: | October 2006 (Final data collection date for primary outcome measure) |
No publications provided by Merck
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):